Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy

Konstantinos N. Fountoulakis, X. Gonda, Thomas C. Baghai, David S. Baldwin, Michael Bauer, Pierre Blier, Wagner Gattaz, Gregor Hasler, Hans Jürgen Möller, Rajiv Tandon, Eduard Vieta, Siegfried Kasper

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Introduction. This report from the World Psychiatric Association Section on Pharmacopsychiatry examines the possible relationship of antiepileptic drugs with suicide-related clinical features and behaviors in patients with epilepsy. Materials and methods. A systematic review of the MEDLINE search returned 1039 papers, of which only 8 were considered relevant. A critical analysis of the Food and Drug Administration (FDA) report on the increase risk for patients under antiepileptics to manifest suicidality is also included in this report. Results. The analysis of these studies revealed that the data are not supportive of the presence of a "class effect" on suicide-related behavior; on the contrary, there are some data suggesting such an effect concerning treatment with topiramate, lamotrigine, and levetiracetam for which further research is needed. Discussion. For the majority of people with epilepsy, anticonvulsant treatment is necessary and its failure for any reason is expected to have deleterious consequences. Therefore, clinicians should inform patients and their families of this increased risk of suicidal ideation and behavior, but should not overemphasize the issue. Specific subgroups of patients with epilepsy might be at a higher risk, and deserve closer monitoring and follow-up. Future research with antiepileptics should specifically focus on depression and suicidal thoughts.

Original languageEnglish
Pages (from-to)158-167
Number of pages10
JournalInternational Journal of Psychiatry in Clinical Practice
Volume19
Issue number3
DOIs
Publication statusPublished - Jul 3 2015

Fingerprint

Anticonvulsants
Epilepsy
etiracetam
Suicide
Suicidal Ideation
United States Food and Drug Administration
MEDLINE
Depression
Therapeutics
Research

Keywords

  • anticonvulsants
  • Antiepileptics
  • suicidality

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy. / Fountoulakis, Konstantinos N.; Gonda, X.; Baghai, Thomas C.; Baldwin, David S.; Bauer, Michael; Blier, Pierre; Gattaz, Wagner; Hasler, Gregor; Möller, Hans Jürgen; Tandon, Rajiv; Vieta, Eduard; Kasper, Siegfried.

In: International Journal of Psychiatry in Clinical Practice, Vol. 19, No. 3, 03.07.2015, p. 158-167.

Research output: Contribution to journalArticle

Fountoulakis, KN, Gonda, X, Baghai, TC, Baldwin, DS, Bauer, M, Blier, P, Gattaz, W, Hasler, G, Möller, HJ, Tandon, R, Vieta, E & Kasper, S 2015, 'Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy', International Journal of Psychiatry in Clinical Practice, vol. 19, no. 3, pp. 158-167. https://doi.org/10.3109/13651501.2014.1000930
Fountoulakis, Konstantinos N. ; Gonda, X. ; Baghai, Thomas C. ; Baldwin, David S. ; Bauer, Michael ; Blier, Pierre ; Gattaz, Wagner ; Hasler, Gregor ; Möller, Hans Jürgen ; Tandon, Rajiv ; Vieta, Eduard ; Kasper, Siegfried. / Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy. In: International Journal of Psychiatry in Clinical Practice. 2015 ; Vol. 19, No. 3. pp. 158-167.
@article{9a900cac555c4200b1b424f46c64fcca,
title = "Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy",
abstract = "Introduction. This report from the World Psychiatric Association Section on Pharmacopsychiatry examines the possible relationship of antiepileptic drugs with suicide-related clinical features and behaviors in patients with epilepsy. Materials and methods. A systematic review of the MEDLINE search returned 1039 papers, of which only 8 were considered relevant. A critical analysis of the Food and Drug Administration (FDA) report on the increase risk for patients under antiepileptics to manifest suicidality is also included in this report. Results. The analysis of these studies revealed that the data are not supportive of the presence of a {"}class effect{"} on suicide-related behavior; on the contrary, there are some data suggesting such an effect concerning treatment with topiramate, lamotrigine, and levetiracetam for which further research is needed. Discussion. For the majority of people with epilepsy, anticonvulsant treatment is necessary and its failure for any reason is expected to have deleterious consequences. Therefore, clinicians should inform patients and their families of this increased risk of suicidal ideation and behavior, but should not overemphasize the issue. Specific subgroups of patients with epilepsy might be at a higher risk, and deserve closer monitoring and follow-up. Future research with antiepileptics should specifically focus on depression and suicidal thoughts.",
keywords = "anticonvulsants, Antiepileptics, suicidality",
author = "Fountoulakis, {Konstantinos N.} and X. Gonda and Baghai, {Thomas C.} and Baldwin, {David S.} and Michael Bauer and Pierre Blier and Wagner Gattaz and Gregor Hasler and M{\"o}ller, {Hans J{\"u}rgen} and Rajiv Tandon and Eduard Vieta and Siegfried Kasper",
year = "2015",
month = "7",
day = "3",
doi = "10.3109/13651501.2014.1000930",
language = "English",
volume = "19",
pages = "158--167",
journal = "International Journal of Psychiatry in Clinical Practice",
issn = "1365-1501",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy

AU - Fountoulakis, Konstantinos N.

AU - Gonda, X.

AU - Baghai, Thomas C.

AU - Baldwin, David S.

AU - Bauer, Michael

AU - Blier, Pierre

AU - Gattaz, Wagner

AU - Hasler, Gregor

AU - Möller, Hans Jürgen

AU - Tandon, Rajiv

AU - Vieta, Eduard

AU - Kasper, Siegfried

PY - 2015/7/3

Y1 - 2015/7/3

N2 - Introduction. This report from the World Psychiatric Association Section on Pharmacopsychiatry examines the possible relationship of antiepileptic drugs with suicide-related clinical features and behaviors in patients with epilepsy. Materials and methods. A systematic review of the MEDLINE search returned 1039 papers, of which only 8 were considered relevant. A critical analysis of the Food and Drug Administration (FDA) report on the increase risk for patients under antiepileptics to manifest suicidality is also included in this report. Results. The analysis of these studies revealed that the data are not supportive of the presence of a "class effect" on suicide-related behavior; on the contrary, there are some data suggesting such an effect concerning treatment with topiramate, lamotrigine, and levetiracetam for which further research is needed. Discussion. For the majority of people with epilepsy, anticonvulsant treatment is necessary and its failure for any reason is expected to have deleterious consequences. Therefore, clinicians should inform patients and their families of this increased risk of suicidal ideation and behavior, but should not overemphasize the issue. Specific subgroups of patients with epilepsy might be at a higher risk, and deserve closer monitoring and follow-up. Future research with antiepileptics should specifically focus on depression and suicidal thoughts.

AB - Introduction. This report from the World Psychiatric Association Section on Pharmacopsychiatry examines the possible relationship of antiepileptic drugs with suicide-related clinical features and behaviors in patients with epilepsy. Materials and methods. A systematic review of the MEDLINE search returned 1039 papers, of which only 8 were considered relevant. A critical analysis of the Food and Drug Administration (FDA) report on the increase risk for patients under antiepileptics to manifest suicidality is also included in this report. Results. The analysis of these studies revealed that the data are not supportive of the presence of a "class effect" on suicide-related behavior; on the contrary, there are some data suggesting such an effect concerning treatment with topiramate, lamotrigine, and levetiracetam for which further research is needed. Discussion. For the majority of people with epilepsy, anticonvulsant treatment is necessary and its failure for any reason is expected to have deleterious consequences. Therefore, clinicians should inform patients and their families of this increased risk of suicidal ideation and behavior, but should not overemphasize the issue. Specific subgroups of patients with epilepsy might be at a higher risk, and deserve closer monitoring and follow-up. Future research with antiepileptics should specifically focus on depression and suicidal thoughts.

KW - anticonvulsants

KW - Antiepileptics

KW - suicidality

UR - http://www.scopus.com/inward/record.url?scp=84941009056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941009056&partnerID=8YFLogxK

U2 - 10.3109/13651501.2014.1000930

DO - 10.3109/13651501.2014.1000930

M3 - Article

VL - 19

SP - 158

EP - 167

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

SN - 1365-1501

IS - 3

ER -